AERI Stock Recent News

Aerie (AERI) enters into an agreement with Alcon to be acquired for $770 million. Shares gain.

Alcon agrees to acquire Aerie, the ophthalmic therapies company, for $15.25 a share.

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Hans Vitzthum – Investor Relations Raj Kannan – Chief Executive Officer Peter Lang – Chief Financial Officer Gary Sternberg – Chief Medical Officer Michelle Senchyna – Head-Clinical Development and Operations Casey Kopczynski – Co-Founder, Head-Research and External Innovation Conference Call Participants Serge Belanger – Needham Annabel Samimy – Stifel Stacy Ku – Cowen Greg Fraser – Truist Operator Good afternoon. Thank you for standing by, and welcome to the Aerie Pharmaceuticals Second Quarter 2022 Earnings Conference Call.

Aerie (AERI) Q2 loss narrows year over year and revenues beat estimates in the second quarter of 2022.

Aerie (AERI) delivered earnings and revenue surprises of 38.46% and 2.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that it will present second quarter 2022 financial results after the market closes Thursday, August 4, 2022. Following the release, Aerie will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss Aerie's financial results and provide a general business update

Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye disease.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Partners Raj Kannan – Chief Executive Officer Gary Sternberg – Chief Medical Officer Peter Lang – Chief Financial Officer Conference Call Participants Louise Chen – Cantor Serge Belanger – Needham & Company Annabel Samimy – Stifel Stacy Ku – Cowen and Company François Brisebois – Oppenheimer Carly Kenselaar – Citigroup Oren Livnat – H.C. Wainwright Operator Good afternoon.

Aerie (AERI) misses on both earnings and revenues for the first quarter of 2022.